{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:41:20Z","timestamp":1791981680923,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03996-8","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:06:27Z","timestamp":1749009987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The potential value of serum pepsinogen and gastrin-17 for the diagnosis of chronic atrophic gastritis at different stages of severity: a clinical diagnostic study"],"prefix":"10.1186","volume":"25","author":[{"given":"Tianyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"3","key":"3996_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"3996_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.20892\/j.issn.2095-3941.2022.0231","volume":"19","author":"C Maomao","year":"2022","unstructured":"Maomao C, He L, Dianqin S, et al. Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022;19(8):1121\u201338.","journal-title":"Cancer Biol Med"},{"issue":"8","key":"3996_CR3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/ijc.29227","volume":"136","author":"H Zeng","year":"2015","unstructured":"Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003\u20132005: a population-based study. Int J Cancer. 2015;136(8):1921\u201330.","journal-title":"Int J Cancer"},{"issue":"4","key":"3996_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"P Pimentel-Nunes","year":"2019","unstructured":"Pimentel-Nunes P, Lib\u00e2nio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of Gastrointestinal endoscopy (ESGE), European Helicobacter and microbiota study group (EHMSG), European society of pathology (ESP), and sociedade Portuguesa de endoscopia digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365\u201388.","journal-title":"Endoscopy"},{"issue":"8\u2013S","key":"3996_CR5","first-page":"88","volume":"89","author":"KI Rodriguez-Castro","year":"2018","unstructured":"Rodriguez-Castro KI, Franceschi M, Noto A, et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018;89(8\u2013S):88\u201392. Published 2018 Dec 17.","journal-title":"Acta Biomed"},{"key":"3996_CR6","doi-asserted-by":"publisher","first-page":"h3867","DOI":"10.1136\/bmj.h3867","volume":"351","author":"H Song","year":"2015","unstructured":"Song H, Ekheden IG, Zheng Z, Ericsson J, Nyr\u00e9n O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867.","journal-title":"BMJ"},{"issue":"13","key":"3996_CR7","doi-asserted-by":"publisher","first-page":"17182","DOI":"10.18632\/oncotarget.7946","volume":"7","author":"XZ Chen","year":"2016","unstructured":"Chen XZ, Sch\u00f6ttker B, Castro FA, et al. Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study. Oncotarget. 2016;7(13):17182\u201393.","journal-title":"Oncotarget"},{"issue":"4","key":"3996_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/07853898909149209","volume":"21","author":"P Sipponen","year":"1989","unstructured":"Sipponen P. Atrophic gastritis as a premalignant condition. Ann Med. 1989;21(4):287\u201390.","journal-title":"Ann Med"},{"issue":"12","key":"3996_CR9","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.20892\/j.issn.2095-3941.2022.0655","volume":"19","author":"H Xu","year":"2022","unstructured":"Xu H, Li W. Early detection of gastric cancer in China: progress and opportunities. Cancer Biol Med. 2022;19(12):1622\u20138.","journal-title":"Cancer Biol Med"},{"issue":"28","key":"3996_CR10","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3748\/wjg.v22.i28.6385","volume":"22","author":"C Hamashima","year":"2016","unstructured":"Hamashima C. Benefits and harms of endoscopic screening for gastric cancer. World J Gastroenterol. 2016;22(28):6385\u201392.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"3996_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/apt.14248","volume":"46","author":"RM Zagari","year":"2017","unstructured":"Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46(7):657\u201367.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"3996_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1136\/gutjnl-2018-317556","volume":"68","author":"Q Cai","year":"2019","unstructured":"Cai Q, Zhu C, Yuan Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576\u201387.","journal-title":"Gut"},{"issue":"4","key":"3996_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4149\/neo_2018_180825N647","volume":"66","author":"G Yu","year":"2019","unstructured":"Yu G, Wang GX, Wang HG, Mo FF, Tang BB. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer. Neoplasma. 2019;66(4):637\u201340.","journal-title":"Neoplasma"},{"issue":"4","key":"3996_CR14","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.21873\/anticanres.15645","volume":"42","author":"K Syrj\u00e4nen","year":"2022","unstructured":"Syrj\u00e4nen K. Accuracy of serum biomarker panel (GastroPanel\u00ae) in the diagnosis of atrophic gastritis of the corpus. Systematic review and Meta-analysis. Anticancer Res. 2022;42(4):1679\u201396.","journal-title":"Anticancer Res"},{"issue":"4","key":"3996_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","volume":"166","author":"YC Chen","year":"2024","unstructured":"Chen YC, Malfertheiner P, Yu HT, et al. Global prevalence of Helicobacter pylori infection and incidence of gastric Cancer between 1980 and 2022. Gastroenterology. 2024;166(4):605\u201319.","journal-title":"Gastroenterology"},{"issue":"2","key":"3996_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jcmgh.2016.12.001","volume":"3","author":"SF Moss","year":"2016","unstructured":"Moss SF. The clinical evidence linking Helicobacter pylori to gastric Cancer. Cell Mol Gastroenterol Hepatol. 2016;3(2):183\u201391. Published 2016 Dec 27.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"19","key":"3996_CR17","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jnci\/92.19.1607","volume":"92","author":"WC You","year":"2000","unstructured":"You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000;92(19):1607\u201312.","journal-title":"J Natl Cancer Inst"},{"key":"3996_CR18","doi-asserted-by":"crossref","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161\u20131181.","DOI":"10.1097\/00000478-199610000-00001"},{"issue":"1","key":"3996_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ueg2.12507","volume":"12","author":"Y Li","year":"2024","unstructured":"Li Y, Jiang F, Wu CY, Leung WK. Prevalence and Temporal trend of gastric preneoplastic lesions in Asia: A systematic review with meta-analysis. United Eur Gastroenterol J. 2024;12(1):139\u201351.","journal-title":"United Eur Gastroenterol J"},{"issue":"9","key":"3996_CR20","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1136\/gutjnl-2019-318640","volume":"69","author":"L Costa","year":"2020","unstructured":"Costa L, Corre S, Michel V, et al. USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis. Gut. 2020;69(9):1582\u201391.","journal-title":"Gut"},{"key":"3996_CR21","doi-asserted-by":"publisher","first-page":"652574","DOI":"10.3389\/fonc.2021.652574","volume":"11","author":"Y Tong","year":"2021","unstructured":"Tong Y, Wang H, Zhao Y, et al. Diagnostic value of serum pepsinogen levels for screening gastric Cancer and atrophic gastritis in asymptomatic individuals: A Cross-Sectional study. Front Oncol. 2021;11:652574.","journal-title":"Front Oncol"},{"issue":"25","key":"3996_CR22","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.3748\/wjg.v26.i25.3673","volume":"26","author":"L Yuan","year":"2020","unstructured":"Yuan L, Zhao JB, Zhou YL, et al. Type I and type II Helicobacter pylori infection status and their impact on Gastrin and pepsinogen level in a gastric cancer prevalent area. World J Gastroenterol. 2020;26(25):3673\u201385.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3996_CR23","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/j.1440-1746.2005.03898.x","volume":"20","author":"TL Ang","year":"2005","unstructured":"Ang TL, Fock KM, Dhamodaran S, Teo EK, Tan J. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population. J Gastroenterol Hepatol. 2005;20(10):1603\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"3996_CR24","first-page":"103844","volume":"78","author":"CL Nguyen","year":"2022","unstructured":"Nguyen CL, Dao TT, Phi TN, Nguyen TP, Pham VT, Vu TK. Serum pepsinogen: A potential non-invasive screening method for moderate and severe atrophic gastritis among an Asian population. Ann Med Surg (Lond). 2022;78:103844.","journal-title":"Ann Med Surg (Lond)"},{"issue":"9","key":"3996_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3109\/00365521.2010.487918","volume":"45","author":"A Telaranta-Keerie","year":"2010","unstructured":"Telaranta-Keerie A, Kara R, Paloheimo L, H\u00e4rk\u00f6nen M, Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints. Scand J Gastroenterol. 2010;45(9):1036\u201341.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"3996_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00535-018-1513-8","volume":"54","author":"S Xiao","year":"2019","unstructured":"Xiao S, Li S, Zhou L, Jiang W, Liu J. Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis. J Gastroenterol. 2019;54(3):226\u201337.","journal-title":"J Gastroenterol"},{"issue":"12","key":"3996_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","volume":"378","author":"IJ Choi","year":"2018","unstructured":"Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric Cancer. N Engl J Med. 2018;378(12):1085\u201395.","journal-title":"N Engl J Med"},{"issue":"1","key":"3996_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12876-017-0641-6","volume":"17","author":"Y Tong","year":"2017","unstructured":"Tong Y, Wu Y, Song Z, Yu Y, Yu X. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. BMC Gastroenterol. 2017;17(1):88.","journal-title":"BMC Gastroenterol"},{"issue":"27","key":"3996_CR29","doi-asserted-by":"publisher","first-page":"e26562","DOI":"10.1097\/MD.0000000000026562","volume":"100","author":"H Yu","year":"2021","unstructured":"Yu H, Liu Y, Jiang S, et al. Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects. Med (Baltim). 2021;100(27):e26562.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3996_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/gut.50.1.13","volume":"50","author":"S Lorente","year":"2002","unstructured":"Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut. 2002;50(1):13\u20138.","journal-title":"Gut"},{"issue":"12","key":"3996_CR31","doi-asserted-by":"publisher","first-page":"e23518","DOI":"10.1002\/jcla.23518","volume":"34","author":"W Liu","year":"2020","unstructured":"Liu W, Sun Y, Yuan Y. Analysis of serum gastrin-17 and Helicobacter pylori antibody in healthy Chinese population. J Clin Lab Anal. 2020;34(12):e23518.","journal-title":"J Clin Lab Anal"},{"issue":"48","key":"3996_CR32","first-page":"6562","volume":"13","author":"LP Sun","year":"2007","unstructured":"Sun LP, Gong YH, Wang L, Yuan Y. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. World J Gastroenterol. 2007;13(48):6562\u20137.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3996_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ijc.29005","volume":"136","author":"H Tu","year":"2015","unstructured":"Tu H, Sun L, Dong X, et al. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. Int J Cancer. 2015;136(2):425\u201334.","journal-title":"Int J Cancer"},{"issue":"1","key":"3996_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1443-9573.2007.00278.x","volume":"8","author":"K Miki","year":"2007","unstructured":"Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8(1):8\u201314.","journal-title":"J Dig Dis"},{"issue":"3","key":"3996_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/diagnostics12030695","volume":"12","author":"N Chapelle","year":"2022","unstructured":"Chapelle N, Osmola M, Martin J, et al. Serum pepsinogens combined with new biomarkers testing using chemiluminescent enzyme immunoassay for Non-Invasive diagnosis of atrophic gastritis: A prospective, multicenter study. Diagnostics (Basel). 2022;12(3):695.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"3996_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12876-021-01794-6","volume":"21","author":"Y Tong","year":"2021","unstructured":"Tong Y, Wang H, Zhao Y, et al. Serum pepsinogen levels in different regions of China and its influencing factors: a multicenter cross-sectional study. BMC Gastroenterol. 2021;21(1):264.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"3996_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.14715\/cmb\/2022.68.8.20","volume":"68","author":"M Xiao","year":"2022","unstructured":"Xiao M, Zhang Z, Liao G, Liu M, Chen X. Analysis of the value of Helicobacter pylori test in combination with the determination of plasma Propepsin and Gastrin 17 in screening the precancerous status of gastric Cancer. Cell Mol Biol (Noisy-le-grand). 2022;68(8):110\u20135.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"3996_CR38","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1038\/s41598-020-61472-7","volume":"10","author":"R Wang","year":"2020","unstructured":"Wang R, Chen XZ. Prevalence of atrophic gastritis in Southwest China and predictive strength of serum gastrin-17: A cross-sectional study (SIGES). Sci Rep. 2020;10(1):4523.","journal-title":"Sci Rep"},{"key":"3996_CR39","doi-asserted-by":"publisher","first-page":"6894248","DOI":"10.1155\/2021\/6894248","volume":"2021","author":"H Shen","year":"2021","unstructured":"Shen H, Xiong K, Wu X, et al. The diagnostic value of serum Gastrin-17 and pepsinogen for gastric Cancer screening in Eastern China. Gastroenterol Res Pract. 2021;2021:6894248.","journal-title":"Gastroenterol Res Pract"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03996-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03996-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03996-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:03:01Z","timestamp":1749052981000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03996-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03996-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Rizhao Hospital of Traditional Chinese Medicine (Ethical approval number: AF\/SX-08\/01.0.2024-139). The Ethics Committee of the Rizhao Hospital of Traditional Chinese Medicine waived informed consent from participants because this study involved routinely collected medical data that were managed anonymously at all stages, including the data cleaning and statistical analysis stages.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"428"}}